Iradimed (NASDAQ:IRMD) Updates Q1 2025 Earnings Guidance

Iradimed (NASDAQ:IRMD) updated its first quarter 2025 earnings guidance on Thursday. The company provided earnings per share guidance of 0.390-0.430 for the period, compared to the consensus earnings per share estimate of 0.410. The company issued revenue guidance of $19.2 million-$19.4 million, compared to the consensus revenue estimate of $19.1 million. Iradimed also updated its FY 2025 guidance to 1.710-1.810 EPS.

Analyst Ratings Changes

Separately, StockNews.com cut shares of Iradimed from a “strong-buy” rating to a “buy” rating in a research note on Thursday.

Iradimed Trading Down 8.4 %

Shares of IRMD opened at $55.40 on Friday. Iradimed has a 12-month low of $40.18 and a 12-month high of $63.29. The firm has a 50-day moving average price of $57.16 and a 200 day moving average price of $52.02. The firm has a market capitalization of $701.92 million, a P/E ratio of 37.95 and a beta of 0.82.

Iradimed (NASDAQ:IRMD) last posted its earnings results on Thursday, February 13th. The medical equipment provider reported $0.40 EPS for the quarter, missing analysts’ consensus estimates of $0.45 by ($0.05). Iradimed had a net margin of 26.12% and a return on equity of 23.99%. Equities research analysts predict that Iradimed will post 1.52 earnings per share for the current fiscal year.

Insider Activity at Iradimed

In other Iradimed news, CFO John Glenn sold 2,500 shares of the stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $54.18, for a total value of $135,450.00. Following the transaction, the chief financial officer now directly owns 4,383 shares in the company, valued at $237,470.94. This represents a 36.32 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 37.10% of the stock is owned by corporate insiders.

About Iradimed

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.